United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 18, 2026 · Filed Aug 19, 2026

On Aug 18, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$515.60 for US$4.9M under a trading plan, leaving 324,443 shares. Filed Aug 19, 2026 (Form 4).

Sold
9,500 shares
Price
US$515.60 average (US$509.48 to US$518.65)
Value
US$4.9M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 18, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 18, 2026Common StockSale239US$509.48333,704Indirect
Aug 18, 2026Common StockSale231US$510.47333,473Indirect
Aug 18, 2026Common StockSale170US$511.59333,303Indirect
Aug 18, 2026Common StockSale439US$513.06332,864Indirect
Aug 18, 2026Common StockSale1,264US$514.18331,600Indirect
Aug 18, 2026Common StockSale2,333US$514.99329,267Indirect
Aug 18, 2026Common StockSale1,880US$516.04327,387Indirect
Aug 18, 2026Common StockSale873US$517.09326,514Indirect
Aug 18, 2026Common StockSale1,630US$518.19324,884Indirect
Aug 18, 2026Common StockSale441US$518.65324,443Indirect

Source

View original at SEC

Related